je.st
news
Amgen cholesterol drug meets goal of third late stage trial
2014-01-23 21:17:14| Biotech - Topix.net
A cholesterol fighter developed by Amgen Inc from a new class of medicines succeeded in significantly lowering levels of "bad" LDL cholesterol in a late stage trial in patients unable to tolerate statin drugs, the company said on Thursday.
Tags: late
stage
trial
goal
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||